{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T15:03:44Z","timestamp":1703084624911},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,15]]},"DOI":"10.2146\/ajhp110737","type":"journal-article","created":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T17:54:41Z","timestamp":1343843681000},"page":"1394-1397","source":"Crossref","is-referenced-by-count":4,"title":["Cardiac arrest and possible seizure activity after vincristine injection"],"prefix":"10.1093","volume":"69","author":[{"given":"Angela S.","family":"Lennon","sequence":"first","affiliation":[{"name":"Department of Pharmacy, McGovern-Davison Children\u2019s Health Center, Duke University Medical Center, Durham, NC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Norales","sequence":"additional","affiliation":[{"name":"Baylor University Medical Center, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Division of Hematology\u2013Oncology, Duke University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041607100077600_b1-0691394","volume-title":"Vincristine package insert","year":"2007"},{"key":"2019041607100077600_b2-0691394","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/pbc.21435","article-title":"Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients","volume":"50","author":"Renbarger","year":"2008","journal-title":"Pediatr Blood Cancer."},{"key":"2019041607100077600_b3-0691394","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/088800101753328529","article-title":"Enhanced vincristine neurotoxicity from drug interactions: case report and review of the literature","volume":"18","author":"Sathiapalan","year":"2001","journal-title":"Pediatr Hematol Oncol."},{"key":"2019041607100077600_b4-0691394","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12098-009-0254-3","article-title":"Vincristine induced neurotoxicity in cancer patients","volume":"77","author":"Gomber","year":"2010","journal-title":"Indian J Pediatr."},{"key":"2019041607100077600_b5-0691394","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/pbc.22972","article-title":"Review: risk of azole-enhanced vincristine neurotoxicity in pediatric patients with hematological malignancies: old problem\u2014new dilemma","volume":"57","author":"Pana","year":"2011","journal-title":"Pediatr Blood Cancer."},{"key":"2019041607100077600_b6-0691394","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/pbc.21786","article-title":"Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X","volume":"52","author":"Porter","year":"2009","journal-title":"Pediatr Blood Cancer."},{"key":"2019041607100077600_b7-0691394","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0972-5229.58545","article-title":"Vincristine-induced acute life-threatening hyponatremia resulting in seizure and coma","volume":"13","author":"Nagappa","year":"2009","journal-title":"Indian J Crit Care Med."},{"key":"2019041607100077600_b8-0691394","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/pbc.22845","article-title":"Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia","volume":"56","author":"Egbelakin","year":"2011","journal-title":"Pediatr Blood Cancer."},{"key":"2019041607100077600_b9-0691394","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1124\/jpet.106.118471","article-title":"Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes","volume":"321","author":"Dennison","year":"2007","journal-title":"J Pharmacol Exp Ther."},{"key":"2019041607100077600_b10-0691394","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1124\/dmd.106.009902","article-title":"Selective metabolism of vincristine in vitro by CYP3A5","volume":"34","author":"Dennison","year":"2006","journal-title":"Drug Metab Dispos."},{"key":"2019041607100077600_b11-0691394","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1188\/06.CJON.271-273","article-title":"Preventing vincristine administration errors: does evidence support minibag infusions?","volume":"10","author":"Schulmeister","year":"2006","journal-title":"Clin J Oncol Nurs."},{"key":"2019041607100077600_b12-0691394","unstructured":"National Cancer Institute. Phase III study of combination chemotherapy in pediatric patients with newly diagnosed hepatoblastoma. www.cancer.gov\/clinicaltrials\/search\/view?cdrid=654889&version=HealthProfessional (accessed 2012 May 25)."},{"key":"2019041607100077600_b13-0691394","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00277-006-0201-6","article-title":"Seizures as an adverse drug reaction after therapeutic dose of vincristine","volume":"86","author":"Mahapatra","year":"2007","journal-title":"Ann Hematol."},{"key":"2019041607100077600_b14-0691394","first-page":"1230","volume-title":"AHFS drug information","author":"McEvoy","year":"2007"},{"key":"2019041607100077600_b15-0691394","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1345\/aph.10358","article-title":"Ischemic heart disease associated with vincristine and doxorubicin chemotherapy","volume":"35","author":"Calvo-Romero","year":"2001","journal-title":"Ann Pharmacother."},{"key":"2019041607100077600_b16-0691394","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat Genet."},{"key":"2019041607100077600_b17-0691394","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.athoracsur.2011.03.054","article-title":"Fatal cerebral air embolus complicating multimodality treatment of esophageal cancer","volume":"92","author":"Raja","year":"2011","journal-title":"Ann Thorac Surg."},{"key":"2019041607100077600_b18-0691394","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/69\/16\/1394\/28455288\/ajhp1394.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T07:19:49Z","timestamp":1555399189000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/69\/16\/1394\/5111986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,15]]},"references-count":18,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2012,8,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp110737","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,8,15]]},"published":{"date-parts":[[2012,8,15]]}}}